Get to IND faster

The industry standard from hit identification to development candidate nomination is on average 33-36 months. Charles River’s truly integrated drug discovery programs have reduced this timeline to as little as 24 months through industry experienced, multi-disciplinary teams focused on resource efficiency, scientific excellence and strategic partnerships with clients through all aspects of drug discovery. With numerous technologies for hit identification, coupled with our knowledge-based approach to advance compounds from hit-to-lead into lead optimization, our scientific advisory services team consistently convert leads into successful preclinical development candidates. Meet the Scientific Advisory Team.

John Montana, PhD, Corporate Vice President, Integrated Drug Development and Strategic Projects, discusses the difference between an integrated drug discovery project and a traditional outsourcing project.